Approval · Notice of Compliance 7283 · 2005

VASERETIC: Notice of Compliance 7283

Issued August 9, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 7283
Date: August 9, 2005
Company: Merck Frosst Canada Ltd., Merck Frosst Canada Ltée
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Angiotensin converting enzyme inhibitor, diuretic

Products in this notice

Brand	DIN	Status today
VASERETIC	02242826	Cancelled Post Market
VASERETIC	00657298	Marketed

Medicinal ingredients

ENALAPRIL MALEATE 5 MG per TAB
HYDROCHLOROTHIAZIDE 12.5 MG per TAB
ENALAPRIL MALEATE 10 MG per TAB
HYDROCHLOROTHIAZIDE 25 MG per TAB